Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy

Conditions: Breast Cancer Interventions: Drug: Cisplatin injection and gemcitabine; Drug: Capecitabine tablets Sponsors: Assiut University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials